Abstract P3-04-10: Utility of the Orally Bioavailable Selective Estrogen Receptor Degrader AZD9496 in ESR1 Mutant Preclinical Models of Estrogen Receptor Positive Breast Cancer
Cancer Research（2017）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined